GMAB
Price
$21.09
Change
-$0.35 (-1.63%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
13.29B
87 days until earnings call
IPSC
Price
$0.49
Change
-$0.02 (-3.92%)
Updated
Aug 11, 03:40 PM (EDT)
Capitalization
43.71M
Earnings call today
Interact to see
Advertisement

GMAB vs IPSC

Header iconGMAB vs IPSC Comparison
Open Charts GMAB vs IPSCBanner chart's image
Genmab A/S ADS
Price$21.09
Change-$0.35 (-1.63%)
Volume$4.51K
Capitalization13.29B
Century Therapeutics
Price$0.49
Change-$0.02 (-3.92%)
Volume$400
Capitalization43.71M
GMAB vs IPSC Comparison Chart in %
Loading...
GMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GMAB vs. IPSC commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMAB is a Buy and IPSC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (GMAB: $21.43 vs. IPSC: $0.51)
Brand notoriety: GMAB and IPSC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GMAB: 133% vs. IPSC: 64%
Market capitalization -- GMAB: $13.29B vs. IPSC: $43.71M
GMAB [@Biotechnology] is valued at $13.29B. IPSC’s [@Biotechnology] market capitalization is $43.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GMAB’s FA Score shows that 0 FA rating(s) are green whileIPSC’s FA Score has 0 green FA rating(s).

  • GMAB’s FA Score: 0 green, 5 red.
  • IPSC’s FA Score: 0 green, 5 red.
According to our system of comparison, GMAB is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GMAB’s TA Score shows that 5 TA indicator(s) are bullish while IPSC’s TA Score has 3 bullish TA indicator(s).

  • GMAB’s TA Score: 5 bullish, 6 bearish.
  • IPSC’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, GMAB is a better buy in the short-term than IPSC.

Price Growth

GMAB (@Biotechnology) experienced а -1.56% price change this week, while IPSC (@Biotechnology) price change was -4.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.22%. For the same industry, the average monthly price growth was +31.78%, and the average quarterly price growth was +19.63%.

Reported Earning Dates

GMAB is expected to report earnings on Nov 06, 2025.

IPSC is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+22.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GMAB($13.3B) has a higher market cap than IPSC($43.7M). GMAB YTD gains are higher at: 2.683 vs. IPSC (-49.772). GMAB has higher annual earnings (EBITDA): 1.35B vs. IPSC (-5.99M). GMAB has more cash in the bank: 3.23B vs. IPSC (165M). IPSC has less debt than GMAB: IPSC (52.7M) vs GMAB (143M). GMAB has higher revenues than IPSC: GMAB (3.12B) vs IPSC (115M).
GMABIPSCGMAB / IPSC
Capitalization13.3B43.7M30,435%
EBITDA1.35B-5.99M-22,563%
Gain YTD2.683-49.772-5%
P/E Ratio11.09N/A-
Revenue3.12B115M2,709%
Total Cash3.23B165M1,955%
Total Debt143M52.7M271%
FUNDAMENTALS RATINGS
GMAB: Fundamental Ratings
GMAB
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
42
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
94
SEASONALITY SCORE
1..100
29

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GMABIPSC
RSI
ODDS (%)
Bearish Trend 4 days ago
62%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
63%
Bullish Trend 4 days ago
80%
Momentum
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
71%
Bearish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
68%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
70%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 19 days ago
62%
Bullish Trend 19 days ago
82%
Declines
ODDS (%)
Bearish Trend 12 days ago
69%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
73%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
62%
Bullish Trend 4 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
GMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FLOW32.030.25
+0.78%
Global X U.S. Cash Flow Kings 100 ETF
LSAT40.100.27
+0.67%
LeaderShares® AlphaFctr® Tctcl Fcsd ETF
TNA34.920.17
+0.49%
Direxion Daily Small Cap Bull 3X ETF
SCDV24.320.11
+0.46%
Bahl & Gaynor Small Cap Dividend ETF
PRN164.100.13
+0.08%
Invesco Dorsey Wright IndustrialsMomtETF

GMAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, GMAB has been loosely correlated with TECH. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if GMAB jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GMAB
1D Price
Change %
GMAB100%
-5.55%
TECH - GMAB
39%
Loosely correlated
+0.54%
ARVN - GMAB
38%
Loosely correlated
+0.80%
IPSC - GMAB
37%
Loosely correlated
-4.14%
IMNM - GMAB
36%
Loosely correlated
-1.82%
IMTX - GMAB
36%
Loosely correlated
-2.22%
More

IPSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with CRSP. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
-4.14%
CRSP - IPSC
57%
Loosely correlated
-1.72%
IMNM - IPSC
52%
Loosely correlated
-1.82%
ARWR - IPSC
52%
Loosely correlated
+2.24%
NTLA - IPSC
51%
Loosely correlated
-5.85%
KYTX - IPSC
50%
Loosely correlated
-2.11%
More